TickerFactsScreenerDevelopers

Moderna, Inc. (MRNA) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2015: $159.04M2016: $50.08M2017: $134.86M2018: $658.36M2019: $236.00M2020: $2.62B2021: $6.85B2022: $3.21B2023: $2.91B2024: $1.93B2025: $2.60B$2.60B
2015Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$2.60B+34.7%
2024$1.93B-33.7%
2023$2.91B-9.3%
2022$3.21B-53.2%
2021$6.85B+161.0%
2020$2.62B+1011.9%
2019$236.00M-64.2%
2018$658.36M+388.2%
2017$134.86M+169.3%
2016$50.08M-68.5%
2015$159.04M—